Last reviewed · How we verify
G001 Topical Gel
G001 Topical Gel is a topical corticosteroid used to reduce inflammation and itching in various skin conditions.
G001 Topical Gel is a topical corticosteroid used to reduce inflammation and itching in various skin conditions. Used for Severe eczema, Psoriasis.
At a glance
| Generic name | G001 Topical Gel |
|---|---|
| Sponsor | BUZZZ Pharmaceuticals Limited |
| Drug class | Topical corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 2 |
Mechanism of action
G001 Topical Gel works by inhibiting the production of inflammatory mediators in the skin, thereby reducing redness, swelling, and itching. This is achieved through its corticosteroid mechanism of action, which is similar to other topical corticosteroids like hydrocortisone.
Approved indications
- Severe eczema
- Psoriasis
Common side effects
- Skin atrophy
- Hypersensitivity reactions
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- G001 Topical Gel CI brief — competitive landscape report
- G001 Topical Gel updates RSS · CI watch RSS
- BUZZZ Pharmaceuticals Limited portfolio CI